GV 2019, L.P.
CIK 0001845041 Name as filed on the most recent filing
Filed as GV 2019, L.P. (26)
83 transaction lines · from 26 filings · filed 2022-10-26 to 2026-07-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Ethos Technologies Inc. 7 filings
- ISSUER Prime Medicine, Inc. 16 filings
- ISSUER Verve Therapeutics, Inc. 3 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-28 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 118,138 disposed | 18.90 | 2,232,760.94 | Form 4, filing 0001168404-26-000041 | |
| 2026-07-27 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 196,931 disposed | 19.46 | 3,832,848.36 | Form 4, filing 0001168404-26-000041 | |
| 2026-07-24 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 23,417 disposed | 18.88 | 442,000.56 | Form 4, filing 0001168404-26-000039 | |
| 2026-07-23 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 63,297 disposed | 19.06 | 1,206,269.92 | Form 4, filing 0001168404-26-000039 | |
| 2026-07-22 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 49,582 disposed | 19.23 | 953,466.82 | Form 4, filing 0001168404-26-000036 | |
| 2026-07-21 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 22,700 disposed | 19.05 | 432,423.65 | Form 4, filing 0001168404-26-000036 | |
| 2026-07-21 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 200 disposed | 19.72 | 3,944.00 | Form 4, filing 0001168404-26-000036 | |
| 2026-07-20 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 18,386 disposed | 18.87 | 346,859.24 | Form 4, filing 0001168404-26-000031 | |
| 2026-07-17 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 20,534 disposed | 18.68 | 383,614.13 | Form 4, filing 0001168404-26-000031 | |
| 2026-07-16 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 19,595 disposed | 18.73 | 367,008.47 | Form 4, filing 0001168404-26-000029 | |
| 2026-07-15 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 61,992 disposed | 19.84 | 1,229,772.50 | Form 4, filing 0001168404-26-000029 | |
| 2026-07-15 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 12,500 disposed | 18.79 | 234,912.50 | Form 4, filing 0001168404-26-000029 | |
| 2026-05-15 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 45,410 disposed | 23.27 | 1,056,649.83 | Form 4, filing 0001168404-26-000025 | |
| 2026-05-15 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 42,065 disposed | 24.27 | 1,020,829.21 | Form 4, filing 0001168404-26-000025 | |
| 2026-05-14 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 60,077 disposed | 23.01 | 1,382,329.72 | Form 4, filing 0001168404-26-000025 | |
| 2026-01-30 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 1,755,632 disposed | 19.00 | 33,357,008.00 | Form 4, filing 0001168404-26-000007 | |
| 2026-01-30 |
Ethos Technologies Inc. LIFE |
S, Open-market sale | 89,676 disposed | 19.00 | 1,703,844.00 | Form 4, filing 0001168404-26-000007 | |
| 2023-06-21 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 19,003 disposed | 14.97 | 284,495.81 | Form 4, filing 0001209191-23-039122 | |
| 2023-06-20 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 37,405 disposed | 15.06 | 563,248.23 | Form 4, filing 0001209191-23-039122 | |
| 2023-06-16 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 6,532 disposed | 15.02 | 98,109.33 | Form 4, filing 0001209191-23-038363 | |
| 2023-06-15 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 66,659 disposed | 14.92 | 994,325.64 | Form 4, filing 0001209191-23-038363 | |
| 2023-06-14 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 28,960 disposed | 14.87 | 430,684.43 | Form 4, filing 0001209191-23-037334 | |
| 2023-06-13 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 28,100 disposed | 15.13 | 425,102.42 | Form 4, filing 0001209191-23-037334 | |
| 2023-06-12 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 16,031 disposed | 14.98 | 240,150.79 | Form 4, filing 0001209191-23-036666 | |
| 2023-06-09 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 15,672 disposed | 14.48 | 226,983.84 | Form 4, filing 0001209191-23-036666 | |
| 2023-06-08 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 5,000 disposed | 15.74 | 78,686.50 | Form 4, filing 0001209191-23-035849 | |
| 2023-06-07 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 15,000 disposed | 16.92 | 253,870.50 | Form 4, filing 0001209191-23-035849 | |
| 2023-06-06 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 29,975 disposed | 17.02 | 510,165.51 | Form 4, filing 0001209191-23-035068 | |
| 2023-06-05 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 22,434 disposed | 16.70 | 374,611.91 | Form 4, filing 0001209191-23-035068 | |
| 2023-06-01 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 44,752 disposed | 14.35 | 642,244.90 | Form 4, filing 0001209191-23-033697 | |
| 2023-06-01 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 471 disposed | 14.75 | 6,948.85 | Form 4, filing 0001209191-23-033697 | |
| 2023-05-31 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 16,633 disposed | 13.65 | 227,003.86 | Form 4, filing 0001209191-23-033697 | |
| 2023-05-30 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 16,805 disposed | 13.70 | 230,240.26 | Form 4, filing 0001209191-23-033107 | |
| 2023-05-26 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 12,602 disposed | 13.70 | 172,603.29 | Form 4, filing 0001209191-23-033107 | |
| 2023-05-25 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 23,161 disposed | 13.38 | 309,972.93 | Form 4, filing 0001209191-23-032529 | |
| 2023-05-24 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 7,900 disposed | 13.66 | 107,920.32 | Form 4, filing 0001209191-23-032529 | |
| 2023-05-23 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 43,939 disposed | 14.74 | 647,647.68 | Form 4, filing 0001209191-23-031916 | |
| 2023-05-22 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 87,922 disposed | 14.13 | 1,242,091.68 | Form 4, filing 0001209191-23-031916 | |
| 2023-05-19 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 63,212 disposed | 13.88 | 877,066.50 | Form 4, filing 0001209191-23-031450 | |
| 2023-05-18 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 14,022 disposed | 13.06 | 183,170.79 | Form 4, filing 0001209191-23-031450 | |
| 2023-05-18 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 13,076 disposed | 13.01 | 170,100.45 | Form 4, filing 0001209191-23-031450 | |
| 2023-05-17 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 15,000 disposed | 12.77 | 191,599.50 | Form 4, filing 0001209191-23-030621 | |
| 2023-05-16 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 50,649 disposed | 12.59 | 637,675.97 | Form 4, filing 0001209191-23-030621 | |
| 2023-05-15 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 157,952 disposed | 12.74 | 2,012,087.35 | Form 4, filing 0001209191-23-029789 | |
| 2023-05-12 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 27,290 disposed | 12.72 | 347,221.59 | Form 4, filing 0001209191-23-029789 | |
| 2023-05-11 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 21,819 disposed | 12.98 | 283,243.35 | Form 4, filing 0001209191-23-029033 | |
| 2023-05-11 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 4,807 disposed | 13.79 | 66,289.97 | Form 4, filing 0001209191-23-029033 | |
| 2023-05-10 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 87,397 disposed | 14.03 | 1,225,804.10 | Form 4, filing 0001209191-23-029033 | |
| 2023-05-09 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 321,238 disposed | 14.08 | 4,522,613.43 | Form 4, filing 0001209191-23-028464 | |
| 2023-05-08 |
Prime Medicine, Inc. PRME |
S, Open-market sale | 100,772 disposed | 14.13 | 1,423,726.97 | Form 4, filing 0001209191-23-028464 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. GV 2019, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001845041
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6